The Role of RamA on the Development of Ciprofloxacin Resistance in Salmonella enterica Serovar Typhimurium
Open Access
- 12 August 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (8) , e23471
Abstract
Active efflux pump is a primary fluoroquinolone resistant mechanism of clinical isolates of Salmonella enterica serovar Typhimurium. RamA is an essential element in producing multidrug resistant (MDR) S.enterica serovar Typhimurium. The aim of the present study was to elucidate the roles of RamA on the development of ciprofloxacin, the first choice for the treatment of salmonellosis, resistance in S. enterica serovar Typhimurium. Spontaneous mutants were selected via several passages of S. enterica serovar Typhimurium CVCC541 susceptible strain (ST) on M-H agar with increasing concentrations of ciprofloxacin (CIP). Accumulation of ciprofloxacin was tested by the modified fluorometric method. The expression levels of MDR efflux pumps were determined by real time RT-PCR. In ST and its spontaneous mutants, the ramA gene was inactivated by insertion of the kan gene and compensated on a recombinant plasmid pGEXΦ(gst-ramA). The mutant prevention concentration (MPC) and mutant frequencies of ciprofloxacin against ST and a spontaneous mutant in the presence, absence and overexpression of RamA were tested. Four spontaneous mutants (SI1-SI4) were obtained. The SI1 (CIP MICs, 0.1 mg/L) without any target site mutation in its quinolone resistant determining regions (QRDRs) and SI3 (CIP MICs, 16 mg/L) harboring the Ser83→Phe mutation in its QRDR of GyrA strains exhibited reduced susceptibility and resistance to multidrugs, respectively. In SI1, RamA was the main factor that controlled the susceptibility to ciprofloxacin by activating MdtK as well as increasing the expression level of acrAB. In SI3, RamA played predominant role in ciprofloxacin resistance via increasing the expression level of acrAB. Likewise, the deficiency of RamA decreased the MPCs and mutant frequencies of ST and SI2 to ciprofloxacin. In conclusion, the expression of RamA promoted the development of ciprofloxacin resistant mutants of S. enterica serovar Typhimurium. The inhibition of RamA could decrease the appearance of the ciprofloxacin resistant mutants.Keywords
This publication has 49 references indexed in Scilit:
- Experimental identification and characterization of 97 novel npcRNA candidates in Salmonella enterica serovar TyphiNucleic Acids Research, 2010
- Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella TyphimuriumJournal of Antimicrobial Chemotherapy, 2008
- RamA Confers Multidrug Resistance in Salmonella enterica via Increased Expression of acrB , Which Is Inhibited by ChlorpromazineAntimicrobial Agents and Chemotherapy, 2008
- AcrAB Multidrug Efflux Pump Regulation in Salmonella enterica serovar Typhimurium by RamA in Response to Environmental SignalsJournal of Biological Chemistry, 2008
- ramR Mutations Involved in Efflux-Mediated Multidrug Resistance in Salmonella enterica Serovar TyphimuriumAntimicrobial Agents and Chemotherapy, 2008
- Structural Asymmetry of AcrB Trimer Suggests a Peristaltic Pump MechanismScience, 2006
- Ciprofloxacin-Resistant Salmonella enterica Serovar Typhimurium Strains Are Difficult To Select in the Absence of AcrB and TolCAntimicrobial Agents and Chemotherapy, 2006
- Salmonella entericaSerovar Typhimurium RamA, Intracellular Oxidative Stress Response, and Bacterial VirulenceInfection and Immunity, 2004
- Structural Basis of Multiple Drug-Binding Capacity of the AcrB Multidrug Efflux PumpScience, 2003
- Emerging Mechanisms of Fluoroquinolone ResistanceEmerging Infectious Diseases, 2001